AMENDMENT #3 TO THE RESEARCH, DEVELOPMENT AND MARKETING COLLABORATION AGREEMENT BETWEEN ONYX PHARMACEUTICALS, INC. AND WARNER-LAMBERT COMPANYResearch, Development and Marketing Collaboration Agreement • November 14th, 2001 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 14th, 2001 Company IndustryTHIS AMENDMENT #3 to the Research, Development and Marketing Collaboration Agreement dated as of July 31, 1997 (“Third Amendment”) is made and entered into on August 6, 2001 (the “Amendment Date”), by and between Onyx Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 3031 Research Drive, Richmond, California 94806 (“Onyx”), and the Warner-Lambert Company, a Delaware corporation and a wholly-owned subsidiary of Pfizer Inc, having a place of business at 2800 Plymouth Road, Ann Arbor, MI 48105 ("Warner").
AMENDMENT #3 TO THE AMENDED AND RESTATED RESEARCH, DEVELOPMENT AND MARKETING COLLABORATION AGREEMENT BETWEEN ONYX PHARMACEUTICALS, INC. AND WARNER-LAMBERT COMPANYResearch, Development and Marketing Collaboration Agreement • November 14th, 2001 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 14th, 2001 Company IndustryTHIS AMENDMENT #3 to the Amended and Restated Research, Development and Marketing Collaboration Agreement dated as of May 2, 1995 (“Third Amendment”) is made and entered into on August 6, 2001 (the “Amendment Date”), by and between Onyx Pharmaceuticals, Inc., a Delaware corporation having its principal place of business at 3031 Research Drive, Richmond, California 94806 (“Onyx”), and the Warner-Lambert Company, a Delaware corporation and a wholly-owned subsidiary of Pfizer Inc, having a place of business at 2800 Plymouth Road, Ann Arbor, MI 48105 ("Warner").
AMENDMENT #1 TO THE COLLABORATION AGREEMENT BETWEEN ONYX PHARMACEUTICALS, INC. AND WARNER-LAMBERT COMPANYCollaboration Agreement • November 14th, 2001 • Onyx Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 14th, 2001 Company IndustryTHIS AMENDMENT #1 to the Collaboration Agreement (the “Amendment”) is made and entered into on August 6, 2001 (the “Amendment Date”), by and between ONYX PHARMACEUTICALS, INC., a Delaware corporation having its principal place of business at 3031 Research Drive, Richmond, California 94806 (“Onyx”), and the Warner-Lambert Company, a Delaware corporation and a wholly-owned subsidiary of Pfizer Inc, having a place of business at 2800 Plymouth Road, Ann Arbor, MI 48105 ("Warner"). Onyx and Warner may be referred to herein individually as a “Party” and collectively as the “Parties.”